Immune-Onc Therapeutics (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- January 06, 2023
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $131,000,000
Company Info
- Founders
- Charlene Liao
- Company Description
- Immune-Onc Therapeutics is a newly established biopharmaceutical company that develops therapeutic antibodies for cancer treatment.
- Market
- Cancer Immunotherapy
- Location
- Palo Alto, California, USA
- Coinvestors
- Leukemia & Lymphoma Society Therapy Acceleration Program, Proxima VC, Triwise Capital, WuXi Biologics